Position in HLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,061,688
-$52,637,027 QoQ
Shares Held
5,300,868
-49.3% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sculptor Capital LP holds $612,815 across 3 Drug Manufacturers - Specialty & Generic names.
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,061,688 | 5,300,868 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $105,698,715 | 10,454,868 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $89,250,315 | 9,949,868 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $103,180,131 | 9,949,868 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $111,645,141 | 10,849,868 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $84,782,914 | 8,887,098 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $94,025,496 | 8,887,098 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $73,407,429 | 8,887,098 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,955,382 | 5,295,098 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $43,578,656 | 5,295,098 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $44,108,166 | 5,295,098 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $54,885,371 | 6,549,567 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $47,560,701 | 5,842,838 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $16,420,224 | 2,052,528 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,416,895 | 3,352,528 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||